Expanding CLIA-certified Contract Research and Clinical Diagnostics Laboratory Secures CAP Approval

Inanovate hires new CEO to help drive next phase of growth and bring novel new blood testing technology for cancer into the clinic.

POMS Corporation unveils a game changer in MES Dashboards & Batch Records for Pharma, Biotech, and Cell and Gene manufacturers. POMSnet Falcon swoops in and shatters the paradigm of electronic batch record visualization with a stunning original design. Go faster and see farther with POMSnet Falcon.

Aalto Bio Reagents announces its SARS nCOV 2 Nucleocapsid protein and Monoclonals to NP are capable of detecting the conserved nucleoprotein Domain of SARS-CoV-2 variants of interest including Omicron B.1.1.529.

Renova Therapeutics Inc, a leader in the development of gene therapies for cardiovascular diseases and diabetes, announced the appointment of Dr. Vijay Mahant to the position of CEO, effective as of Sept. 16, 2021.

"Best-Pal" shampoo and deodorant join the sustainable wellness company's line of high-performing, organic, eco-friendly, non-toxic products

Presentation to include clinical data from Aronora's phase 2 study of AB002, a first-in-class protein C activator enzyme that is being developed for the treatment and prevention of thrombotic and inflammatory diseases.

Biopharmaceutical research company leverages positive data on its cannabinoid-containing mixtures to develop new cytokine release syndrome therapies

Efforts are underway to spread cheer and give back to their community this holiday season.

Novel sustained-release technology has potential to eliminate the need for eye drops after cataract surgery.

Sustainable wellness innovator is latest company to join region's research and development hub, capitalizing on Tampa Bay's professional talent, logistical resources, and quality of life.

Biopharmaceutical research company pursues faster route for drug discovery using PhAROS™, Gb Sciences' AI-enabled drug discovery platform, and through efficiency in their drug development pipeline leveraging strong relationships

Biotech to Offer Employees Access to Quality and Affordable Child Care Options via First-of-its-Kind Platform

Proceeds from this financing will support the development of the Company's proprietary platform, which leverages the inherent capacity of NK cells to distinguish between normal and diseased tissues.

New digital pathology, quantitative image analysis and quantitative AI method for liver tissues is presented for the continuous assessment of the histological phenotype(s) of fibrosis, including severity and regression of fibrosis in Human in-vitro 3D NASH Spheroid models, NASH rodent models, Clinical Phase2b NASH Studies at the Liver Meeting Digital Experience™ 2021

Thirty-three Navy SEAL veterans were treated with a bone marrow mesenchymal stem cell (MSC) derived extracellular vesicle isolate product (EVIP) for Osteoarthritis (OA) of the knee, shoulder, elbow, hip, ankle, or wrist.

The biopharma technology company's AI-driven PhAROS™ platform has identified novel, plant-inspired formulations that will be tested using preclinical Zebrafish models at the National Research Council of Canada.

Clinically relevant model validates Neo-Islets™ as a durable and potentially curative therapy for Type 1 Diabetes that does not require toxic anti-rejection drugs

Expanding their mission-based diagnostics services

A philanthropic event that gives back to their local community throughout December.

Demco Automation develops automated manufacturing systems using new robotic technologies to a growing list of industries, including life science, pharmaceuticals, biotech, medical device, defense, aerospace, electronics, commercial/industrial products, semiconductors, and consumer products.

KoreConX's partnership leads a transformation for Life Sciences, Healthcare, Biotech, Medtech and Pharma businesses for capital raising

The life sciences innovation catalyst will celebrate the grand opening of its Culver City collaboration hub with a week of events in partnership with other LA life sciences organizations

New Snapshot methods for low-coverage sequencing bring hidden data to life

Based on a recently completed preclinical study performed at Michigan State University, Gb Sciences' preclinical data supports further development of their novel cannabinoid-containing complex mixtures as anti-inflammatory therapies for hyperinflammatory conditions associated with COVID-19 and other life-threatening inflammatory conditions.

Highlighting Gb Sciences' Development of Plant-Inspired Therapies for COVID-related Cytokine Release Syndrome, Chronic Pain, and Parkinson's Disease during the Healthcare & Biotech Track starting Monday, September 13.